The Goldman Sachs Group, Inc. 13D and 13G filings for Silence Therapeutics plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-12 6:15 pm Sale | 2023-12-29 | 13G | Silence Therapeutics plc SLN | GOLDMAN SACHS GROUP INC GS | 2,316,169 2.200% | -2,224,994 (-49.00%) | Filing |
| 2023-02-08 3:09 pm Purchase | 2022-12-30 | 13G | Silence Therapeutics plc SLN | GOLDMAN SACHS GROUP INC GS | 4,541,163 5.100% | 4,541,163 (New Position) | Filing |